Insiders Nanomix Corporation

Equities

NNMX

US63008H2013

Delayed OTC Markets Other stock markets 01:25:08 2023-12-29 pm EST			5-day change	1st Jan Change
0.0001 ^USD	-.--%		-.--%	-.--%

2023	Nanomix Corporation Announces Chief Executive Officer Changes	CI
2023	Nanomix Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nanomix Corporation Announces Chief Executive Officer Changes	Nov. 24	CI
Nanomix Corporation Appoints Christopher R. Hetterly as Chief Financial Officer	23-01-25	CI
Nanomix Names Tadd S. Lazarus to Board of Directors	22-08-31	CI
Nanomix Corporation Appoints Tadd S. Lazarus to its Board of Directors as Independent Director	22-08-31	CI
Nanomix Corporation Appoints Thomas Schlumpberger as Member of the Board of Directors	22-07-26	CI
Nanomix Corporation Announces Executive Changes	22-07-26	CI
Nanomix Corporation Appoints Vidur Sahney as Chief Operating Officer	22-03-30	CI
Nanomix, Inc. has Changed its Name to Nanomix Corporation	21-11-15	CI
Boston Therapeutics, Inc. Announces Board Changes	21-06-10	CI
Boston Therapeutics, Inc. Announces Resignation of Mr. Conroy Cheng, as Its Chief Financial Officer	21-06-10	CI
Boston Therapeutics, Inc. Announces Resignation of Conroy Cheng, as Its Chief Executive Officer	21-06-10	CI
Boston Therapeutics, Inc. Appoints Conroy Cheng as the Interim Chief Executive Officer and Interim Chief Financial Officer	20-01-10	CI
Boston Therapeutics, Inc Announces Resignation of S. Colin Neill as Member of Board and Audit Committee	19-09-25	CI
Boston Therapeutics, Inc. Announces Resignation of Loraine V. Upham as Chief Operating Officer	18-12-06	CI
Boston Therapeutics, Inc. Announces Board Changes	18-03-29	CI
Boston Therapeutics Creates New Scientific Advisory Board	18-03-27	CI
Boston Therapeutics, Inc Announces New Coo, Loraine V. Upham	18-02-20	CI
Rom Eliaz Resigns as Director of Boston Therapeutics, Inc	17-06-19	CI
Boston Therapeutics, Inc. Appoints Carl W. Rausch as Director	16-12-01	CI
Alan M. Hoberman Resigns as Director of Boston Therapeutics, Inc	16-11-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Nanomix Corporation

Equities

NNMX

US63008H2013

Insiders

Filters